RECURRENT NEUROFIBROMATOSIS TYPE 1

Clinical trials for RECURRENT NEUROFIBROMATOSIS TYPE 1 explained in plain language.

Never miss a new study

Get alerted when new RECURRENT NEUROFIBROMATOSIS TYPE 1 trials appear

Sign up with your email to follow new studies for RECURRENT NEUROFIBROMATOSIS TYPE 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for kids with Tough-to-Treat brain tumors

Disease control Ongoing

This study tested a drug called selumetinib for children and young adults whose low-grade brain tumors came back or didn't respond to prior treatment. The goal was to find a safe dose and see if the drug could shrink or control the tumors. Participants took the drug as a pill twi…

Matched conditions: RECURRENT NEUROFIBROMATOSIS TYPE 1

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

RECURRENT NEUROFIBROMATOSIS TYPE 1

Get alerted when new RECURRENT NEUROFIBROMATOSIS TYPE 1 trials appear

New hope for kids with Tough-to-Treat brain tumors